MedPath

(SPARROW) Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple’s procedure (SPARROW): a multicenter, randomized controlled trial

Phase 1
Conditions
Pancreatoduodenectomy with a high risk for contaminated bile
Therapeutic area: Diseases [C] - Neoplasms [C04]
Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Registration Number
CTIS2024-510766-16-00
Lead Sponsor
Academisch Ziekenhuis Leiden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
344
Inclusion Criteria

Patients undergoing elective pancreatoduodenectomy with a high risk for contaminated bile defined as patients with preoperative biliary drainage or an ampullary malignancy., Age >18 years

Exclusion Criteria

Pregnancy, Contraindication for the study antibiotics (e.g. allergy or intolerance), Indication for endocarditis prophylaxis, Preoperative planned therapeutic antibiotic treatment after surgery (i.e. for cholangitis or liver abscesses), A reduced renal function, defined as a eGFR of <60 ml/min/1.73m2 and measured on a the closest timepoint prior to pancreatoduodenectomy

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath